CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Noncontrolling Interest [Member]	Total
Balance at Sep. 30, 2020	$ 5,144	$ 275,548,737	$ (269,835,650)	$ (8,725)	$ 5,709,506
Balance (in shares) at Sep. 30, 2020	5,142,779
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of warrants	$ 519	2,605,010			2,605,529
Exercise of warrants (in shares)	518,551
Fair value of warrants issued in connection with public offering		1,643,440			1,643,440
Stock based compensation expense		571,498			571,498
Net loss			(4,809,556)	2,494	(4,807,062)
Balance at Dec. 31, 2020	$ 5,663	280,368,685	(274,645,206)	(6,231)	5,722,911
Balance (in shares) at Dec. 31, 2020	5,661,330
Balance at Sep. 30, 2020	$ 5,144	275,548,737	(269,835,650)	(8,725)	5,709,506
Balance (in shares) at Sep. 30, 2020	5,142,779
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss					(6,324,140)
Balance at Mar. 31, 2021	$ 7,488	294,781,015	(276,162,006)	(6,509)	18,619,988
Balance (in shares) at Mar. 31, 2021	7,486,120
Balance at Dec. 31, 2020	$ 5,663	280,368,685	(274,645,206)	(6,231)	5,722,911
Balance (in shares) at Dec. 31, 2020	5,661,330
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in public offering, net of offering costs	$ 1,810	13,754,697			13,756,507
Common stock issued in public offering, net of offering costs (in shares)	1,810,000
Exercise of warrants	$ 2	8,398			8,400
Exercise of warrants (in shares)	1,600
Exercise of options cashlessly	$ 13	(13)
Exercise of options cashlessly (in shares)	13,190
Stock based compensation expense		649,248			649,248
Net loss			(1,516,800)	(278)	(1,517,078)
Balance at Mar. 31, 2021	$ 7,488	294,781,015	(276,162,006)	(6,509)	18,619,988
Balance (in shares) at Mar. 31, 2021	7,486,120
Balance at Sep. 30, 2021	$ 7,488	295,228,272	(284,122,092)	(722)	$ 11,112,946
Balance (in shares) at Sep. 30, 2021	7,486,120				7,486,120
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation expense		1,699,920			$ 1,699,920
Options issued in settlement of accrued bonus		300,000			300,000
Net loss			(4,721,766)	855	(4,720,911)
Balance at Dec. 31, 2021	$ 7,488	297,228,192	(288,843,858)	133	8,391,955
Balance (in shares) at Dec. 31, 2021	7,486,120
Balance at Sep. 30, 2021	$ 7,488	295,228,272	(284,122,092)	(722)	$ 11,112,946
Balance (in shares) at Sep. 30, 2021	7,486,120				7,486,120
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss					$ (6,480,708)
Balance at Mar. 31, 2022	$ 8,236	298,351,897	(290,712,648)	(979)	$ 7,646,506
Balance (in shares) at Mar. 31, 2022	8,234,320				8,234,320
Balance at Dec. 31, 2021	$ 7,488	297,228,192	(288,843,858)	133	$ 8,391,955
Balance (in shares) at Dec. 31, 2021	7,486,120
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in public offering, net of offering costs	$ 748	4,091,085			4,091,833
Common stock issued in public offering, net of offering costs (in shares)	748,200
Deemed dividend - warrant repricing		110,105	(110,105)
Fair value of warrants issued in connection with public offering		(3,350,400)			(3,350,400)
Stock based compensation expense		272,915			272,915
Net loss			(1,758,685)	(1,112)	(1,759,797)
Balance at Mar. 31, 2022	$ 8,236	$ 298,351,897	$ (290,712,648)	$ (979)	$ 7,646,506
Balance (in shares) at Mar. 31, 2022	8,234,320				8,234,320